Breaking News
January 16, 2018 - Johns Hopkins gets approval to perform HIV positive to HIV positive living donor kidney transplants
January 16, 2018 - The Salk Institute and Indivumed collaborate for cutting-edge cancer research
January 16, 2018 - Study reveals negative long-term effects of heavy cannabis use on brain function and behavior
January 16, 2018 - Many gym-goers injure themselves by pushing harder to be better than friends
January 16, 2018 - Risankizumab Meets All Primary Endpoints Reporting Positive Results in Fourth Pivotal Phase 3 Psoriasis Study
January 16, 2018 - Federal Junk Food Tax Feasible, Study Says
January 16, 2018 - Do girls have stronger teeth than boys?
January 16, 2018 - New high-sensitivity blood tests could aid faster diagnosis and treatment for heart attack
January 16, 2018 - TherapeuticsMD Announces FDA Acceptance of New Drug Application and Prescription Drug User Fee Act (PDUFA) Date for TX-004HR
January 16, 2018 - Morning Break: Food Pharmacies; Obamacare Sign-ups Dip; Top Pot Studies
January 16, 2018 - Blood pressure declines 14 to 18 years before death
January 16, 2018 - Researchers use immune-mimicking biomaterial scaffolds to fast track T cell therapies
January 16, 2018 - Bile acids could directly burn away lipids in the fat depots
January 16, 2018 - Cycling does not negatively impact sexual and urinary health finds study
January 16, 2018 - Severe peer victimization in childhood may contribute to mental health issues in adolescence
January 16, 2018 - Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for Previously Untreated Advanced Renal Cell Carcinoma
January 16, 2018 - Just How Often Do Patients Turn Post-Surgical Opioids Into a Habit?
January 16, 2018 - Opioid addiction – Genetics Home Reference
January 16, 2018 - Incomplete revascularization in PCI linked to higher mortality
January 16, 2018 - Machine learning algorithm uses brain scans to predict language ability in deaf children
January 16, 2018 - Penn scientists identify new therapeutic target for treatment of melanoma
January 16, 2018 - The London Clinic exhibits innovative technology to treat Parkinson’s disease at Arab Health
January 16, 2018 - Early influenza testing is critical to prevent serious complications
January 16, 2018 - Study Gets to the Core of Back Pain in Runners
January 16, 2018 - Year in Review: Ophthalmology | Medpage Today
January 16, 2018 - ClinicalTrials.gov: Marijuana Use
January 16, 2018 - Researchers create novel compound targeting melanoma cells
January 16, 2018 - FDA grants approval for first drug to treat inherited breast cancer
January 16, 2018 - Researchers develop remote-controlled mechanogenetics system to target and kill cancer cells
January 16, 2018 - Fresh, Frozen Embryos Equal in IVF
January 16, 2018 - Research shows biological clocks could improve brain cancer treatment
January 16, 2018 - Dire view from within accident and emergency wards of England and Wales
January 16, 2018 - Study reveals how devastating mitochondrial diseases strike families without any previous history
January 16, 2018 - Experts look for ways to standardize treatments for pediatric rheumatic diseases
January 16, 2018 - Teens who watch TV shows with ads likely to eat more junk food
January 16, 2018 - Aztec apocalypse found to be Salmonella outbreak
January 16, 2018 - Stealth BioTherapeutics Granted Fast Track Designation for Elamipretide for the Treatment of Leber’s Hereditary Optic Neuropathy
January 16, 2018 - Three Ineffective Institutional Approaches to Quality Improvement in Healthcare
January 16, 2018 - New technology accelerates autism diagnosis and treatment
January 16, 2018 - Preterm babies likely to experience delays in auditory brain development, study reveals
January 16, 2018 - Research sheds new light on genetic, environmental factors that promote prostate cancer metastasis
January 16, 2018 - Mitochondrial impairment may actually protect the brain in Parkinson’s disease, study shows
January 15, 2018 - Energy drinks can have adverse health effects on youth, study reveals
January 15, 2018 - 60° Pharmaceuticals (60P) Submits New Drug Application to US FDA for Antimalarial Drug Tafenoquine
January 15, 2018 - Wanted: ‘Breathalyzer’ for Cannabis Use
January 15, 2018 - Surfers more likely to get antibiotic resistant E. coli in their guts
January 15, 2018 - “Baby brain” a real clinical entity finds study
January 15, 2018 - Whole of Britain to be put on a diet plan come March
January 15, 2018 - Neighborhood Deprivation Linked to Heart Failure
January 15, 2018 - Omega-3 and Omega-6 fatty acid intake may affect lupus outcomes
January 15, 2018 - Scientists discover new enzyme that could reduce obesity rates
January 15, 2018 - Evidence suggests two patterns of early symptoms precede and predict later BD risk
January 15, 2018 - Harm minimization approach for smoking cessation with e-cigarettes
January 15, 2018 - Surgery or Antibiotics for Appendicitis? Here’s What Patients Chose
January 15, 2018 - ASH: Frailty Screening Tool Guides Therapy in Elderly
January 15, 2018 - Study shows video games could cut dementia risk in seniors
January 15, 2018 - Common Food Additive Promoting C. diff?
January 15, 2018 - Mild traumatic brain injury causes long-term damage in mice
January 15, 2018 - Circadian clock proteins set the pace of plant growth
January 15, 2018 - Two proteins shown to regenerate brain in Parkinson’s disease
January 15, 2018 - Jotting down tasks may ease falling asleep, study says
January 15, 2018 - Chi-Med Initiates Fruquintinib U.S. Clinical Trials
January 15, 2018 - Cell-Free DNA May Help Pinpoint Breast Ca Survival
January 15, 2018 - What goes on inside a medically supervised injection facility?
January 15, 2018 - Research provides new model to better ascertain HIV mortality rates in Zambia
January 15, 2018 - Genetic analysis can enhance outcomes of depression treatment
January 15, 2018 - Variations in bacterial strains can trigger varying immune responses, study states
January 15, 2018 - TherapeuticsMD Announces Resubmission of New Drug Application for TX-004HR
January 15, 2018 - HIV Vaccine Shows ‘Positive Signal’ in Small Study
January 15, 2018 - Researchers demonstrate RAS dimers are essential for cancer
January 15, 2018 - Groundbreaking report highlights plan to end bowel cancer
January 15, 2018 - Doc Aspires to Bring ‘Medicine the Musical’ to Off-Broadway
January 15, 2018 - Does an exploding brain network cause chronic pain?
January 15, 2018 - Researchers use novel PET tracer to assess myelin damage in mouse models of MS
January 15, 2018 - Survival strategy of mRNAs during sugar deficiency in the cell
January 15, 2018 - Hormone Therapy May Ease Depression Linked to Menopause
January 15, 2018 - Pain Sensitization Declines After Bariatric Tx in Obese Patients
January 15, 2018 - C7 nerve transfer improves function in spastic arm paralysis
January 15, 2018 - Australian kids are drinking and smoking far less than before
January 15, 2018 - Worsening of anxiety symptoms may be early indicator of Alzheimer’s disease
FDA Wants New Nicotine Replacement Products

FDA Wants New Nicotine Replacement Products

image_pdfDownload PDFimage_print

Action Points

  • The U.S. Food and Drug Administration (FDA) has announced a change in strategy for regulating nicotine replacement therapy (NRT) products, with the aim of ushering in new products that can help cigarette smokers quit.
  • The FDA noted that a primary focus of the new committee will be on existing nicotine delivery treatments, including prescription products and those currently sold over-the-counter in the form of gums, patches, and lozenges.

The FDA has announced a change in strategy for regulating nicotine replacement therapy (NRT) products, with the aim of ushering in new products that can help cigarette smokers quit.

In a blog post published on the agency’s site on Wednesday afternoon, FDA Commissioner Scott Gottlieb, MD, and two other agency officials announced the formation of a Nicotine Steering Committee charged with “re-evaluating and modernizing” FDA’s approach to NRTs.

The post noted that a primary focus of the committee will be existing nicotine delivery treatments, including prescription products and those currently sold over-the-counter in the form of gums, patches, and lozenges.

“This reflects the need to critically examine the evolving science behind FDA’s evaluation of the safety and efficacy of NRTs. Key topics will be the types of safety and efficacy studies we require and the way these products are used and labeled,” wrote Gottlieb, along with Center for Drug Evaluation and Research Director Janet Woodcock, MD, and Center for Tobacco Products Director Mitch Zeller, JD.

Last summer, FDA officials announced a dramatic shift in tobacco policy, with the goal of slashing nicotine levels in combustible cigarettes to non-addictive levels and exploring the potential of new nicotine delivery products like e-cigarettes and heat-not-burn devices as nicotine replacement therapies.

The FDA is currently reviewing Philip Morris International’s application to allow its heat-not-burn product IQOS to be marketed in the U.S. as a modified risk tobacco product. The agency is expected to rule on the application by early next year.

In Wednesday’s blog post, the officials reaffirmed the commitment to, “rendering combustible cigarettes minimally — or non-addictive,” as well as the commitment to offering reduced-harm products to replace them.

“If there are new kinds of NRTs — with different characteristics or routes of delivery — that can offer additional opportunities for smokers to quit combustible tobacco, we want to explore what steps we can take using our own regulatory policies to enable these opportunities, while making sure these products are demonstrated to be safe and effective for their intended use.”

The FDA blog noted that while nearly half of smokers try to quit combustible cigarettes each year, only a small percentage are successful.

In a study published this week in the BMJ journal Tobacco Control, researchers with Georgia State University’s Tobacco Center of Regulatory Science in Atlanta found that the vast majority of smokers they surveyed wanted to quit smoking and wished they had never picked up the habit.

The nationally representative survey of close to 1,300 adult smokers found that more than 80% reported high (22.5%) or very high (59.8%) discontent regarding their inability to quit smoking, their perceived addiction, and their decision to start smoking.

High levels of discontent did not vary significantly by sex, age, race/ethnicity, education, or income.

Compared with smokers expressing low (5.9%) or very low (3.6%) discontent regarding their smoking status, smokers expressing higher levels of discontent were more than twice as likely to perceive their health status as fair or poor (adjusted OR 2.3), more than four times as likely to worry about lung cancer (adjusted OR 4.6), and more than five times as likely to feel that they might develop lung cancer in the future (adjusted OR 5.1).

In an interview with MedPage Today, the lead researcher, Terry Frank Pechacek, PhD, said the findings have implications for federal regulators as they consider moving forward in the regulation of tobacco products and nicotine-delivery devices.

Pechacek said FDA officials and others should recognize that most smokers do want to quit. In addition, regulators should not put much emphasis on the “lost pleasure” aspect of quitting smoking, he said.

The FDA is required to perform an economic cost-benefit analysis of proposed regulations, and the agency has included the lost pleasure measure in its analysis of cigarette regulations.

Pechacek said there is significant debate about how the benefit-cost analysis of tobacco regulation should be conducted. He said federal regulators should focus on estimating net welfare gains from quitting smoking rather than emphasizing any lost pleasure in policy analyses.

“Our study found that most smokers express regret about starting smoking and they wish they could quit. These people are not continuing to smoke because they derive pleasure from the habit.”

Grant support for the research was provided by the National Institute on Drug Abuse and the Food and Drug Administration Center for Tobacco Products.

The researchers reported having no relevant relationships with industry.

  • Reviewed by
    Robert Jasmer, MD Associate Clinical Professor of Medicine, University of California, San Francisco and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2017-11-30T17:15:00-0500

Tagged with:

About author

Related Articles